These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18331731)

  • 1. Novel computational models for predicting dopamine interactions.
    Katritzky AR; Dobchev DA; Stoyanova-Slavova IB; Kuanar M; Bespalov MM; Karelson M; Saarma M
    Exp Neurol; 2008 May; 211(1):150-71. PubMed ID: 18331731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease.
    Volpini R; Dal Ben D; Lambertucci C; Marucci G; Mishra RC; Ramadori AT; Klotz KN; Trincavelli ML; Martini C; Cristalli G
    ChemMedChem; 2009 Jun; 4(6):1010-9. PubMed ID: 19343763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.
    Rolls ET; Loh M; Deco G; Winterer G
    Nat Rev Neurosci; 2008 Sep; 9(9):696-709. PubMed ID: 18714326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on the interactions of scorpion neurotoxins with the predicted structure of D1 dopamine receptor by protein-protein docking method. A bioinformatics approach.
    Sudandiradoss C; Priya Doss CG; Rajasekaran R; Ramanathan K; Purohit R; Sethumadhavan R
    C R Biol; 2008 Jul; 331(7):489-99. PubMed ID: 18558372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, dopaminergic profile, and molecular dynamics calculations of N-aralkyl substituted 2-aminoindans.
    Andujar SA; de Angel BM; Charris JE; Israel A; Suárez-Roca H; López SE; Garrido MR; Cabrera EV; Visbal G; Rosales C; Suvire FD; Enriz RD; Angel-Guío JE
    Bioorg Med Chem; 2008 Mar; 16(6):3233-44. PubMed ID: 18166467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of central dopamine in pain and analgesia.
    Wood PB
    Expert Rev Neurother; 2008 May; 8(5):781-97. PubMed ID: 18457535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P
    Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of delays and noise on dopamine signal transduction.
    Wu J; Qi Z; Voit EO
    In Silico Biol; 2010; 10(1):67-80. PubMed ID: 22430222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead hopping using SVM and 3D pharmacophore fingerprints.
    Saeh JC; Lyne PD; Takasaki BK; Cosgrove DA
    J Chem Inf Model; 2005; 45(4):1122-33. PubMed ID: 16045307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structural and functional organization of the cerebral dopaminergic system].
    Barishpolets VV; Fedotova IuO; Sapronov NS
    Eksp Klin Farmakol; 2009; 72(3):44-9. PubMed ID: 19642593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
    Aranda R; Villalba K; Raviña E; Masaguer CF; Brea J; Areias F; Domínguez E; Selent J; López L; Sanz F; Pastor M; Loza MI
    J Med Chem; 2008 Oct; 51(19):6085-94. PubMed ID: 18783204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse models of dopamine deficiency.
    Chen L; Zhuang X
    Ann Neurol; 2003; 54 Suppl 6():S91-102. PubMed ID: 12891659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
    Sass MB; Lorenz AN; Green RL; Coleman RA
    J Neurosci Methods; 2009 Apr; 178(2):366-77. PubMed ID: 19136028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking study of A(3) adenosine receptor antagonists and pharmacophore-based drug design.
    Wei J; Li H; Qu W; Gao Q
    Neurochem Int; 2009 Dec; 55(7):637-42. PubMed ID: 19540293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral dopaminergic system. Basic and clinical advances.
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):1S-2S. PubMed ID: 1974437
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine/serotonin receptor ligands. Part 17: a cross-target SAR approach: affinities of azecine-styled ligands for 5-HT(2A) versus D1 and D2 receptors.
    Enzensperger C; Görnemann T; Pertz HH; Lehmann J
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3809-13. PubMed ID: 18534847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method for protein-ligand binding affinity prediction and the related descriptors exploration.
    Li S; Xi L; Wang C; Li J; Lei B; Liu H; Yao X
    J Comput Chem; 2009 Apr; 30(6):900-9. PubMed ID: 18785151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.